Clinical Trial Update: Measuring the Neuroimmune Response to Alcohol [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing the neuroimmune response to alcohol has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Drinking
• Alcohol Use Disorder
• Alcohol-related Conditions

Snippet

Sponsor: Yale University | Conditions: Alcohol Drinking | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2023-11-07